Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)

This study has been completed.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Muscular Dystrophy Association
Information provided by (Responsible Party):
Jerry R. Mendell, Nationwide Children's Hospital Identifier:
First received: June 27, 2007
Last updated: February 4, 2013
Last verified: February 2013